• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination

tetano

Editor, Senior Moderator
Front Immunol


. 2023 Feb 9;14:1123724.
doi: 10.3389/fimmu.2023.1123724. eCollection 2023.
Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination


Domenico Lo Tartaro[SUP] 1 [/SUP], Annamaria Paolini[SUP] 1 [/SUP], Marco Mattioli[SUP] 1 [/SUP], Julian Swatler[SUP] 1 2 [/SUP], Anita Neroni[SUP] 1 [/SUP], Rebecca Borella[SUP] 1 [/SUP], Elena Santacroce[SUP] 1 [/SUP], Alessia Di Nella[SUP] 1 [/SUP], Licia Gozzi[SUP] 3 [/SUP], Stefano Busani[SUP] 4 5 [/SUP], Michela Cuccorese[SUP] 6 [/SUP], Tommaso Trenti[SUP] 6 [/SUP], Marianna Meschiari[SUP] 3 [/SUP], Giovanni Guaraldi[SUP] 3 4 [/SUP], Massimo Girardis[SUP] 4 5 [/SUP], Cristina Mussini[SUP] 3 4 [/SUP], Katarzyna Piwocka[SUP] 2 [/SUP], Lara Gibellini[SUP] 1 [/SUP], Andrea Cossarizza[SUP] 1 7 [/SUP], Sara De Biasi[SUP] 1 [/SUP]



Affiliations

Abstract

The formation of a robust long-term antigen (Ag)-specific memory, both humoral and cell-mediated, is created following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or vaccination. Here, by using polychromatic flow cytometry and complex data analyses, we deeply investigated the magnitude, phenotype, and functionality of SARS-CoV-2-specific immune memory in two groups of healthy subjects after heterologous vaccination compared to a group of subjects who recovered from SARS-CoV-2 infection. We find that coronavirus disease 2019 (COVID-19) recovered patients show different long-term immunological profiles compared to those of donors who had been vaccinated with three doses. Vaccinated individuals display a skewed T helper (Th)1 Ag-specific T cell polarization and a higher percentage of Ag-specific and activated memory B cells expressing immunoglobulin (Ig)G compared to those of patients who recovered from severe COVID-19. Different polyfunctional properties characterize the two groups: recovered individuals show higher percentages of CD4[SUP]+[/SUP] T cells producing one or two cytokines simultaneously, while the vaccinated are distinguished by highly polyfunctional populations able to release four molecules, namely, CD107a, interferon (IFN)-γ, tumor necrosis factor (TNF), and interleukin (IL)-2. These data suggest that functional and phenotypic properties of SARS-CoV-2 adaptive immunity differ in recovered COVID-19 individuals and vaccinated ones.

Keywords: B cells; SARS-CoV-2; T cells; antigen-specific response; cytokine; polyfunctionality.
 
Back
Top Bottom